| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/01/1999 | CA2280950A1 Use of amino phenol amide derivatives as depigmentation agents |
| 06/30/1999 | EP0925357A1 Human cns cell lines and methods of use therefor |
| 06/30/1999 | EP0925356A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 06/30/1999 | EP0925308A2 Compositions and methods for treating infections using analogues of indolicidin |
| 06/30/1999 | EP0925305A1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 06/30/1999 | EP0925304A1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 06/30/1999 | EP0925070A1 Antifungal combination therapy |
| 06/30/1999 | EP0925069A1 Means for treating prostate hypertrophy and prostate cancer |
| 06/30/1999 | EP0925064A1 5-ANDROSTENE 3 beta,17alpha DIOL AS AN INHIBITOR OF TUMOR GROWTH |
| 06/30/1999 | EP0925060A1 Fast decomposing pellets |
| 06/30/1999 | EP0924985A1 Method for inhibiting the expression of fas |
| 06/30/1999 | EP0526540B1 Use of 5-ht4-receptor antagonists in the treatment of atrial fibrillation, including the prevention of stroke |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221349A Cellular vaccines immunotherapeutics and methods for their preparation |
| 06/30/1999 | CN1221342A Oxa acids and related compounds for treating skin conditions |
| 06/30/1999 | CN1221339A Use of inhibitors of cellular Na+/H+ exchanger (NHE) for preparing medicament for normalizing serum lipids |
| 06/30/1999 | CN1221338A Use of H2-antagonists for manufacture of topical composition for treatment of colds |
| 06/29/1999 | US5916912 Orally administering to the host an effective dosage of a carnitine, such as acetyl-l-carnitine, and a mitochondrially active antioxidant, such as lipoic acid; restores mitochondiral functions; mitigation of indicia of aging |
| 06/29/1999 | US5916910 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
| 06/29/1999 | US5916906 Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin B6 |
| 06/29/1999 | US5916769 Polynucleotides encoding extra cellular/epidermal growth factor HCABA58X polypepides |
| 06/29/1999 | US5916766 Human marco scavenger receptor |
| 06/29/1999 | US5916596 Water insoluble drugs and drug delivery |
| 06/29/1999 | US5916589 Pharmaceutical compositions comprising cyclosporins |
| 06/29/1999 | US5916579 Process for combating adiposity and compositions which may be used for this purpose |
| 06/29/1999 | US5916560 Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith |
| 06/29/1999 | CA2097823C Therapy for pulmonary vasoconstriction and asthma |
| 06/24/1999 | WO1999031509A1 Improved method for the identification and characterization of interacting molecules using automation |
| 06/24/1999 | WO1999031280A1 Screening assays for the detection and diagnosis of influenza virus |
| 06/24/1999 | WO1999031268A1 Agonists of metabotropic glutamate receptors and uses thereof |
| 06/24/1999 | WO1999031267A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development |
| 06/24/1999 | WO1999031265A1 Compounds and methods for the inhibition of protein-protein interactions |
| 06/24/1999 | WO1999031252A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031225A2 Human phosphatases |
| 06/24/1999 | WO1999031140A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/24/1999 | WO1999031136A2 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031060A2 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 06/24/1999 | WO1999030764A1 Systems and methods for local delivery of an agent |
| 06/24/1999 | WO1999030740A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999030735A1 UGC (UPSTREAM GENE OF cdsA) |
| 06/24/1999 | WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | WO1999030727A1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030709A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030708A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | WO1999030706A1 ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
| 06/24/1999 | WO1999030697A2 Combination effective for the treatment of impotence |
| 06/24/1999 | WO1999030696A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | WO1999030560A1 Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | CA2730373A1 Treatment of cancer having overexpression of erbb2 with anti-erbb2 antibodies and a hormonal chemotherapeutic agent |
| 06/24/1999 | CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | CA2315540A1 Agonists of metabotropic glutamate receptors and uses thereof |
| 06/24/1999 | CA2315527A1 Human phosphatases |
| 06/24/1999 | CA2315370A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | CA2315232A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315224A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | CA2314993A1 Combination effective for the treatment of impotence |
| 06/24/1999 | CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 06/24/1999 | CA2314884A1 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | CA2314821A1 Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
| 06/24/1999 | CA2314431A1 Screening assays for the detection and diagnosis of influenza virus |
| 06/24/1999 | CA2314422A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development |
| 06/24/1999 | CA2313448A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | CA2312913A1 Compounds and methods for the inhibition of protein-protein interactions |
| 06/24/1999 | CA2312347A1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | CA2311932A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | CA2311896A1 Improved method for the identification and characterization of interacting molecules using automation |
| 06/24/1999 | CA2299397A1 Antihyperlipidemic statin-lp(a) inhibitor combinations |
| 06/23/1999 | EP0923740A2 Methods and compositions for the detection of cervical cancer |
| 06/23/1999 | EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/23/1999 | EP0923644A1 G-coupled receptor showing selective affinity for atp |
| 06/23/1999 | EP0923399A1 Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| 06/23/1999 | EP0923378A1 Promotion of wound healing by chemically-modified tetracyclines |
| 06/23/1999 | EP0923375A2 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl heterocyclic compound |
| 06/23/1999 | EP0923370A2 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method |
| 06/23/1999 | EP0689452B1 Composition for oral administration of peptides |
| 06/23/1999 | CN1220701A Lipid kinase |
| 06/23/1999 | CN1220608A Mammalian tolloid-like gene and protein |
| 06/23/1999 | CN1043786C Method for preparing antibiotic compound |
| 06/22/1999 | US5914345 Treatment with stimulus to induce altered levels of stress response or hear shock proteins |
| 06/22/1999 | US5914332 Retroviral protease inhibiting compounds |
| 06/22/1999 | US5914322 Treatment of disease and conditions |
| 06/22/1999 | US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue |
| 06/22/1999 | US5914251 Nucleic acid molecules encoding placental-derived growth factors |
| 06/22/1999 | US5914129 Analgesic composition for treatment of migraine headaches |
| 06/22/1999 | US5914118 Multi-layered drug containing film preparation having powder adhesive thereon |
| 06/19/1999 | CA2256303A1 The use of mmp inhibitors for the treatment of ocular angiogenesis |
| 06/17/1999 | WO1999030151A1 Method and cells to screen combinatorial libraries |
| 06/17/1999 | WO1999029896A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
| 06/17/1999 | WO1999029873A1 Cyclic gmp phosphodiesterase |
| 06/17/1999 | WO1999029863A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto |